Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Musculoskeletal Clinical Trial
Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy
Status: Enrolling, Phase III
Updated: 12/31/1969
Mike O'Callaghan Federal Medical Center
mi
from
Nellis Air Force Base, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Corning, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Overland Park, KS
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Cotton-O'Neill Clinical Research Center
mi
from
Topeka, KS
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Downey Medical Center
mi
from
Downey, CA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Intervertebral Disc Degeneration Clinical Trial
Adjacent Segment Mechanics in Cervical Arthrodesis Patients
Status: Enrolling, Phase
Updated: 12/31/1969
University of Pittsburgh Biodynamics Lab
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Heart Failure Clinical Trial
CardiAMP™ Heart Failure Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida - College of Medicine/ div of Cardiovascular Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Heart Failure Clinical Trial
CardiAMP™ Heart Failure Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Heart - St.Joseph Mercy Health System (Trinity Health)
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
St. David's Heart and Vascular dba Austin Heart
mi
from
Austin, TX
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Steward St. Elizabeth's Medical Center
mi
from
Brighton, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
Status: Enrolling, Phase II
Updated: 12/31/1969
Kellogg Cancer Center - NorthShore University
mi
from
Evanston, IL
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease
Status: Enrolling, Phase
Updated: 12/31/1969
Lung Institute Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Brigham Women's Hospital Headache Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Headache Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Northern Arizona Healthcare Medical Group
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Henry Ford Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Preferred Headache Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Headache Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah General Neurology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pneumonia Clinical Trial
Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Alabama - Children's of Alabama - Infectious Diseases/Virology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
DHAT Research Institute
mi
from
Garland, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Tibor Rubin VA Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Crohn's and Colitis Center
mi
from
Miami, FL
Click here to add this to my saved trials
Malignancies Clinical Trial
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Virginia Cancer Care Specialist, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burke, VA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Green Cove Springs, FL
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Maumee, OH
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Coronado, CA
Click here to add this to my saved trials
High-Risk Nevus Phenotype Clinical Trial
Risk Stratification Among Individuals Who Have Many Moles on Their Skin
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Hospital; Cleveland Clinic Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sarah Cannon Research Institute - Kansas City - HCA Midwest Health
mi
from
Kansas City, MO
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology Associates of Kingsport, P.C.
mi
from
Kingsport, TN
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Miami, School of Med; Hem/Onc
mi
from
Miami, FL
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health & Science Uni
mi
from
Portland, OR
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Cancer Cnt Onco Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Breast Fibroadenoma Clinical Trial
Treatment of Breast Fibroadenoma Targeted Tissue With HIFU
Status: Enrolling
Updated: 12/31/1969
New York Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cystinuria Clinical Trial
Bucillamine Phase 2 Trial in Patients With Cystinuria
Status: Enrolling, Phase II
Updated: 4/13/2017
University of Wisconsin School of Medicane and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Plantation, FL
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Lymphoma, Mantle Cell Clinical Trial
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Nh Hematology - Oncology
mi
from
Hooksett, NH
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Torrance Memorial Physican Network
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Temple, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
University of Maryland Greenebaum Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Bozeman Health
mi
from
Bozeman, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
OhioHealth Grady - Delaware Health Center
mi
from
Delaware, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care, Aurora Cancer Care
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Washington University: Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Metro MN Community Oncology Research Consortium (MMCORC)
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care, Aurora Cancer Care
mi
from
West Allis, WI
Click here to add this to my saved trials
Neurology Clinical Trial
Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke
Status: Enrolling
Updated: 4/9/2018
Human Sensorimotor Laboratory, School of Kinesiology, University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Merrillville, IN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Roseburg, OR
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Rosemead, CA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Benioff Children's Hospital at Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
STRIDE Biorepository
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Asthma Clinical Trial
Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year
Status: Enrolling, Phase IV
Updated: 12/31/1969
GSK Investigational Site
mi
from
Loxahatchee Groves, FL
Click here to add this to my saved trials
Cancer Clinical Trial
JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Simmons Cancer Center - Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente San Diego - Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Cancer Center- Hillcrest
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Cancer Institute at Baptist Health, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials